Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together.
Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value — for healthcare systems, providers, and the people they serve.
Learn more at Medtronic.com.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.
Further information is available at www.siemens-healthineers.com.
With Augmedics, the future of surgery is in sight. The Chicago-based company aims to improve healthcare by augmenting surgery with cutting edge technologies that solve unmet clinical needs and instill technological confidence in the surgical workflow. Its pioneering xvision system, the first augmented reality navigation technology to be used in surgery, allows surgeons to see the patient’s anatomy through skin and tissue as if they have “x-ray vision,” allowing them to more accurately navigate instruments and implants during procedures.
For more information, visit www.augmedics.com.
Augmedics’ groundbreaking xvision Spine system (XVS) is the first augmented reality (AR) navigation system to be used in surgery. xvision Spine allows surgeons to visualize their patients’ 3D spinal anatomy during surgery as if they had “x-ray vision,” helping them to accurately navigate instruments and implants while looking directly at the patient, rather than a remote screen. The XVS consists of a transparent near-eye-display headset and all elements of a traditional navigation system. It accurately determines the position of surgical tools, in real-time, and superimposes them on the patient's CT data. The navigation data is then projected onto the surgeon’s retina using the headset, allowing him or her to simultaneously look at the patient and see the navigation data without averting their eyes to a remote screen during the procedure. The system is designed to revolutionize how surgery is done by giving the surgeon better control and visualization, which may lead to easier, faster and safer surgeries.
Created in 2014 in Belgium, AuXin Surgery develops and commercializes a medical device for more selective dissection. CADISS® is based on the combination of a pharmaceutical molecule and non-cutting dissectors. The molecule reduces adhesion between tissues and the non-cutting dissector facilitates mechanically their detachment.
CADISS® system allows pathological tissue to be separated from healthy tissue much more easily and safely, resulting in less damages to healthy organs, with less relapses. It is complementary to existing dissection instruments and may improve significantly the outcome of surgical procedures. Clinical trials over 1000 patients in several pathologies have been performed, with clear outcomes: less side-effects, less relapses and a better preservation of healthy tissues.
CADISS® is registered as CE Class III Medical Devices in the EU for open surgery in Ear Surgery and Musculoskeletal Surgeries (e.g. spine revision surgery, chronic otitis media, etc.) and will be extended in 2022 to laparoscopic -abdominal surgery- applications. For example: in a spine revision surgery, the fibrosis can adhere strongly to the dura mater, which can lead to a tear in this membrane when the fibrosis is removed. The major consequence of such a tear is a leakage of cerebrospinal fluid, which greatly increases the risk of side effects such as brain infections. CADISS® significantly reduces this risk.
The procedure to register CADISS® as Combination Devices in the USA is ongoing since 2019. The distribution network launched since 2019, today covers more than 875 Mio inhabitants in 32 countries (Europe, Latin America, Asia, Middle East and Africa). AuXin manages multiple key activities including products development, supply chain and global marketing strategies, whereas local sales activities are partnered.
A pain-free, active life into old age – this is what everyone wants. Bauerfeind AG, a manufacturer of medical aids, such as supports, orthoses, compression stockings and foot orthoses, makes a major contribution towards this with its numerous innovations.
The medium-sized family business, founded in Zeulenroda, Germany, in 1929, has always placed an emphasis on products that preserve and restore health, as well as improve well-being. Today Bauerfeind AG is one of the industry’s market leaders. The company, which has an international presence, has a total of approximately 2,100 employees worldwide and is represented by subsidiaries in more than 20 countries. The products, however, all bear the respected “Made in Germany” label and some of the production steps involve authentic handcrafting.
Bauerfeind’s therapeutic supports and orthoses have been proven to support the recovery process after injuries and ensure that mobility returns.
VenoTrain medical compression stockings cover all indications associated with modern compression therapy and also offer clinically proven effectiveness, unique material properties and a patient-oriented modern design.
Patented products and systems attest to the innovative strength of the company, such as the pioneering Bodytronic measurement system.
Bauerfeind works closely with people to develop its products. For research and development activities specialists are brought in, be it scientists, physicians, medical retailers or orthotists. Patients’ experiences of and the knowledge gained from providing products to athletes are, however, also incorporated on an ongoing basis into the development and optimization of products – products that are available to everyone.
Proven Product Solutions for over 30 Years
Centinel Spine is the largest privately-held spine company focused on anterior column reconstruction. The company offers a continuum of trusted, brand-name motion-preserving and fusion solutions backed by over 30 years of clinical success — providing the most robust and clinically-proven Total Disc Replacement and Integrated Interbody™ portfolios in the world.
For more information prior to GSC 2021, please visit the company’s website below or contact: firstname.lastname@example.org
Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. Among 400+ spinal bone grafts on the market, spine surgeons can feel confident in choosing i-FACTOR Peptide Enhanced Bone Graft as it is one of only two FDA PMA Approved bone grafts on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years.
i-FACTOR® is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.
i-FACTOR is free of many safety risks seen with other products such as ectopic bone formation and on average costs at least 30% less expensive than other drug-device combination products.
With patient well-being as a priority, Cousin biotech, a French manufacturing company, conceptualizes, ensure global regulatory compliance, manufactures and commercializes implantable medical devices for Spine, Orthopaedics and Visceral surgeries.
Throughout industrial and scientific collaborations, we imagine and materialize innovative surgical solutions to provide surgeons with additional techniques that fit all their patients’ pathologies and conditions.
Thanks to IntraSPINE and B-DYN, our spine portfolio makes dynamic stabilization and motion preservation efficient and globally recognized alternatives to fusion surgeries.
With our sublaminar bands and groundbreaking single-use ancillaries, we bring surgeons worldwide safe and efficient tools to treat spinal correction and deformity.
Visit us in our booth during 2021 GSC event!
All our commercial and technical teams will be thrilled to present our technologies and share their experience and expertise with all of you.
elliquence, LLC manufactures patented Radiowave technology with innovative devices for orthopedic, neurosurgery, and pain management applications. Surgi-Max® Ultra permits precision tissue preservation, non-adherent bipolar effects and surgical versatility. Disc-FX® Discectomy System, Trigger-Flex® steerable bipolar handpiece and a full line of endoscopic spine instruments are examples of the surgical accessories offered for use with the Surgi-Max® Ultra energy source. elliquence focuses on sparing healthy tissue while precisely treating pathology.
FzioMed develops and commercializes absorbable surgical biomaterials based on its patented polymer science, for use in surgical applications including spine, orthopedics, tendon, peripheral nerve, gynecology and general surgery.
- Oxiplex® spine gel helps reduce adhesion formation and related symptoms such as pain.
- Oxiplex/AP® is designed for peritoneal surgery applications.
- Oxiplex/IU® serves to separate surgically traumatized opposing tissue surfaces in the uterine cavity.
- Dynavisc® is an adhesion barrier gel for tendon and peripheral nerve surgeries.
Globus Medical, a leading musculoskeletal solutions company is driving significant technological advancements across a complete suite of products ranging from spinal, trauma and orthopedics therapies to robotics, navigation and imaging. Founded in 2003, Globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with musculoskeletal disorders.
icotec, a Swiss company, designs and manufactures non-metallic spinal implants made from carbon fibre reinforced PEEK (Carbon/PEEK). Carbon/PEEK breaks barriers in radiotherapy: it enables artifact-free CT/MRI images for accurate delineation of critical structures and accelerated dose planning. During radiotherapy, Carbon PEEK is radiolucent, enables homogenous doses and avoids shielding and scattering. Radiation therapy during tumor treatment is no longer limited by metallic implants.
joimax® - Your Expert in Endoscopic Minimally Invasive Spine Surgery
joimax® is the leading provider of complete systems for endoscopic minimally invasive spinal surgery with focus on innovative products, continuous development, and a comprehensive training program.
joimax® offers highly specialized products for endoscopic minimally invasive spinal procedures, displaying its strength in the development of instruments, methods and devices. Our surgical solutions ensure the most gentle treatment, always keeping the best interest of our patients in mind. The outstanding quality of our products is guaranteed by a certified Quality Management System according to international standards. Additionally, all products are “Made in Germany”.
The innovative endoscopic surgical methods of joimax® offer you and your patients state-of-the-art treatment options for a broad range of indications. All of the minimally invasive procedures are performed by using HD-endoscopes: the surgeon inserts the endoscope through a small incision which allows access to the surgical field and direct visualization of the nerve roots. As the surgeon progressively dilates the access through the soft tissue and muscles the problem area can be treated very gently, using instruments with ramping up diameters, and with minimal adverse effect on the surrounding structures.
The joimax® product portfolio is based on 3 pillars covering decompression / deherniation, pain therapy and stabilization methods.
Responding to the divergence of spinal related diagnoses, with each diagnosis and vertebral segment containing its unique challenges, joimax® is constantly expanding its range of methods, instrument sets and corresponding electronic devices.
NGMedical GmbH is an owner-managed company specializing in the development of innovative spinal implants. Many years of experience, combined with a high degree of creativity, give us the impetus to significantly advance the development of spine surgery. The NGMedical team has been developing innovative product systems since 2001. NGMedical derived out of the company Advanced Medical Technologies AG, which was acquired in 2012. NGMedical exploits this longtime experience combined with a high degree of creativity and know-how for the development of further innovative product concepts. Both, earlier and today, the cooperation with a team of experienced surgeons and scientists is the basis for the market-driven orientation. Many product solutions, today accepted and widely used as standards, derive from our team.
In 2020 we launched our first cervical implants to the European market, starting with our unique MOVE-C cervical disc prosthesis. A defined neutral zone and progressive motion resistance help to mimic the natural ROM and quality and make MOVE-C unique. The cervical line was completed by our BEE 3D titanium cage and our BEE HA PEEK-HA cage. BEE titanium combines anatomical design and the abilities of additive manufacturing in an unprecedented way. BEE HA is the perfect match for all surgeons looking for a real anatomical design, radiolucency and bone ingrowth without additional coating. All three cervical implants use the same instrumentation, which makes life easier in the OR.
The iFuse Implant System® by SI-BONE, Inc., is a proprietary MIS implant system, intended for sacroiliac joint fusion, including the use in High and Low Energy fractures of the pelvic ring.
For use in Trauma SI-BONE recommends surgeons to reduce and stabilize the fracture prior to the iFuse placement.
In lumbopelvic deformity fusion cases iFuse-Bedrock is intended to stabilize the SI-joint (2-points-off-fixation) and potentially reduce stress to the S2AI screws.
The 3D-printed triangular shaped implants are designed specifically to stabilize and fuse the heavily loaded SI-joint. Over 55,000 procedures have been performed with the iFuse Implant System® – the-Method-of-Choice-for-SI-Joint-Fusion®. Available since 2009, iFuse is the ONLY Implant for treatment of SI-joint dysfunction supported by significant published clinical evidence, including several level 1 trials, showing safety, effectiveness and durability, including long lasting pain relief.
With the SI-University, SI-BONE offers a unique training program treating degenerative, deformity and trauma related SI-joint pain.
KARL STORZ, a family-owned company founded in Tuttlingen (Germany) in 1945, is a globally recognized market leader and solution provider in endoscopy for human and veterinary medicine. With its innovative endoscopes, instruments, units, services, and integrated solutions, KARL STORZ has stood for reliability, quality, and availability for over 75 years. Its portfolio of endoscopic instruments includes more than 15,000 products. In dialog with medical professionals, KARL STORZ shapes and defines medical progress. Innovation, precision, and creativity are the hallmarks of KARL STORZ’s work. The company combines stability with flexibility, anticipating the future while remaining grounded in tradition.
From its headquarters in Tuttlingen, KARL STORZ has grown from a two-person company into a global corporation that now employs 8,500 people at over 50 subsidiaries and is represented in more than 40 countries.
Carl Zeiss Meditec AG offers a comprehensive line of surgical microscopes and loupes that uncompromisingly enhance visualization during spine surgery. ZEISS supports spine surgeons in seeing more, in effectively managing complex conditions, generating enhanced outcomes and improving patient lives. ZEISS medical loupes provide specialists with high-contrast images at a wide range of magnification levels for detail recognition and differentiation. Surgical microscopes for spine surgery ensure optical precision, flexibility, fast OR setup and ease of use for both surgeon and assistant.